Valuation: LifeTech Scientific Corporation

Market Cap 6.09B 7.17B 914M 812M 751M 681M 1.28B 86.29B 1.3B 9.01B 3.54B 45.33B 3.43B 3.35B 144B P/E 2024
25.7x
P/E 2025 42.5x
Enterprise Value 4.95B 5.82B 742M 660M 610M 553M 1.04B 70.1B 1.06B 7.32B 2.87B 36.82B 2.78B 2.73B 117B EV / Sales 2024
3.74x
EV / Sales 2025 3.91x
Free-Float
77.55%
Yield 2024 *
-
Yield 2025 -
1 day+5.10%
1 week+1.98%
Current month+10.75%
1 month+17.05%
3 months+9.57%
6 months-20.77%
Current year-0.96%
1 week 1.38
Extreme 1.375
1.58
1 month 1.26
Extreme 1.255
1.58
Current year 1.26
Extreme 1.255
2.38
1 year 1.26
Extreme 1.255
2.38
3 years 1.24
Extreme 1.24
2.63
5 years 1.24
Extreme 1.24
4.36
10 years 1.13
Extreme 1.13
5.98
Manager TitleAgeSince
Chief Executive Officer 56 2015-03-01
Director of Finance/CFO 55 2010-08-31
Corporate Officer/Principal - 2026-05-21
Director TitleAgeSince
Chairman 56 2006-08-16
Director/Board Member 63 2014-03-31
Director/Board Member 68 2014-03-31
Date Insider Type Main position Quantity % Market Cap. Importance
5/7/26 Other

Director

16,000,000 0.3454%
5/7/26 Other

Chief Financial Officer

50,000,000 1.0795%
5/7/26 Other

Executive/Senior Manager

21,800,000 0.4707%
Change 5-day change 1-year change 3-year change Capi.($)
+5.10%+1.98%-23.89%-32.83% 868M
+0.97%+4.67%+27.61%+49.46% 254B
+4.29%+4.95%+12.22%+13.62% 158B
-2.26%+1.44%-6.62%+60.40% 155B
-2.35%+2.77%-55.72%-11.07% 66.06B
+0.59%+6.27%+12.12%+59.96% 51.6B
+0.65%+4.48%-13.77%-9.33% 51.82B
+0.12%+3.67%+17.41%+27.23% 50.89B
+2.74%+3.58%+24.30%+62.73% 48.78B
+3.31%+6.59%+33.30%+80.36% 43.51B
Average +1.52%+2.74%+2.70%+30.05% 88B
Weighted average by Cap. +1.23%+3.19%+8.69%+38.47%

Financials

2024 2025
Net sales 1.3B 1.53B 196M 174M 161M 146M 274M 18.47B 278M 1.93B 757M 9.7B 734M 718M 30.92B 1.37B 1.61B 206M 183M 169M 153M 288M 19.41B 292M 2.03B 795M 10.2B 771M 755M 32.49B
Net income 222M 262M 33.37M 29.65M 27.44M 24.86M 46.77M 3.15B 47.48M 329M 129M 1.66B 125M 123M 5.27B 148M 174M 22.18M 19.71M 18.24M 16.53M 31.09M 2.09B 31.56M 219M 85.82M 1.1B 83.19M 81.45M 3.51B
Net Debt -1.18B -1.39B -177M -157M -145M -132M -248M -16.68B -251M -1.74B -683M -8.76B -662M -648M -27.92B -1.14B -1.34B -171M -152M -141M -128M -240M -16.18B -244M -1.69B -663M -8.5B -643M -629M -27.09B
Projected Income Statement - Annual - LifeTech Scientific Corporation
Logo LifeTech Scientific Corporation
LifeTech Scientific Corp is an investment holding company primarily engaged in the development, manufacture and trading of interventional medical devices for cardiovascular and peripheral vascular diseases and disorders. The Company mainly operates its business through three segments. The Structural Heart Diseases Business segment is engaged in trading, manufacture, research and development of devices related to structural heart diseases. The Peripheral Vascular Diseases Business segment is engaged in trading, manufacture, research and development of devices related to peripheral vascular diseases. The Cardiac Pacing and Electrophysiology Business segment is engaged in trading, manufacture, research and development of devices related to cardiac pacing and electrophysiology. The Company conducts its business in the domestic and overseas markets.
Employees
1,254
Date Price Change Volume
26-10-21 HK$1.545 +5.10% 45,026,000
26-10-20 HK$1.470 +3.89% 28,484,000
26-10-16 HK$1.415 +1.07% 13,416,000
26-10-15 HK$1.400 -2.44% 25,290,000
26-10-14 HK$1.435 -5.28% 32,105,100
Trader
-
Investor
-
Global
-
Quality
-
ESG MSCI
BB
MarketScreener Ratings - LifeTech Scientific Corporation

Annual profits - Rate of surprise

Rate of surprise - EPS - Annual - LifeTech Scientific Corporation
  1. Stock Market
  2. Stocks
  3. 1302 Stock